NRSN · NeuroSense Therapeutics Ltd. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-16 | Eisenberg Or |
CFO and Secretary |
Buy↑
Filing footnotes — Ordinary Shares (Direct)
On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. |
Ordinary Shares
|
250,000 |
| 2026-06-16 | Ben-Noon Alon |
Chief Executive Officer, 10% Owner |
Buy↑
Filing footnotes — Ordinary Shares (Direct)
On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. |
Ordinary Shares
|
250,000 |
| 2026-03-26 | Russek-Blum Niva |
Chief Technology Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee or director in connection with the Issuer's 2018 Share Incentive Plan must be registered in the name of a trustee. The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date. |
Ordinary Shares
|
200,000 |
| 2026-03-26 | Binder Hagit |
General Manager |
Award↑
Filing footnotes — Ordinary Shares (Direct)
To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee or director in connection with the Issuer's 2018 Share Incentive Plan must be registered in the name of a trustee. The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date. |
Ordinary Shares
|
200,000 |
| 2026-03-26 | Eisenberg Or |
CFO and Secretary |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date. |
Ordinary Shares
|
200,000 |